Cogentix Medical (CGNT1)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
CEO:
Darin Hammers
Employees:
178
5420 FELTL ROAD, MINNETONKA, MN 55343
952-426-6140

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Cogentix Medical, Inc. engages in the design, development, manufacture and marketing of medical devices and technologies for the urology market. Its products include Urgent PC, Macroplastique, and EndoSheath System. The company was founded in 1987 and is headquartered in Minnetonka, MN.

Data derived from most recent annual or quarterly report
Market Cap 234.487 Million Shares Outstanding60.906 Million Avg 30-day Volume 197.371 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS0.01
Price to Revenue3.4067 Debt to Equity0.0 EBITDA2.404 Million
Price to Book Value2.996 Operating Margin-1.5794 Enterprise Value162.825 Million
Current Ratio4.658 EPS Growth0.986 Quick Ratio3.778
1 Yr BETA 0.0 52-week High/Low 0.0 / Profit Margin-1.5675
Operating Cash Flow Growth-30.1065 Altman Z-Score10.4815 Free Cash Flow to Firm -677.003 Thousand
View SEC Filings from CGNT1 instead.

View recent insider trading info

Funds Holding CGNT1 (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CGNT1 BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SHAMIR NACHUM

  • Director
No longer subject to file 2018-04-23 0

PELL LEWIS C

  • Director
No longer subject to file 2018-04-20 0

REYNOLDS BRETT SVP, CFO, TREASURER

  • Officer
No longer subject to file 2018-04-20 0

SAMET KENNETH A

  • Director
No longer subject to file 2018-04-20 0

GEIGER URI

  • Director
No longer subject to file 2018-04-20 0

HAMMERS DARIN CEO

  • Officer
No longer subject to file 2018-04-20 0

PEGUS CHERYL

  • Director
No longer subject to file 2018-04-20 0

ZAUBERMAN HOWARD I.

  • Director
No longer subject to file 2018-04-20 0

ACCELMED GROWTH PARTNERS, L.P.

ACCELMED GROWTH PARTNERS (GP), L.P.

ACCELMED GROWTH PARTNERS (AGP) LTD

ACCELMED GROWTH PARTNERS MANAGEMENT LTD.

  • 10% Owner
No longer subject to file 2018-04-20 0

D'ORTA JAMES A

  • Director
No longer subject to file 2018-04-20 0

KILL ROBERT CHAIRMAN, PRESIDENT AND CEO

  • Officer
  • Director
544,840 2016-04-21 0

PAULUS KENNETH H

  • Director
47,775 2016-03-07 0

ROCHE KEVIN H

  • Director
101,973 2015-07-31 0

WEHRWEIN SVEN

  • Director
53,998 2015-07-31 0

STAUNER JAMES P

  • Director
70,929 2015-07-31 0

UROPLASTY INC

  • 10% Owner
0 2014-12-21 0

PATEL JITENDRA VP, INDUSTRIAL DIVISION

  • Officer
0 2014-10-21 0

LANDMAN MARK S VP, DISPOSABLES OPERATIONS

  • Officer
0 2014-10-21 0

SIEGEL GARY VP, FINANCE

  • Officer
0 2014-10-21 0

RYDZEWSKI JOHN J

  • Director
102,500 2014-07-31 0

ANDERSON DAVID W

  • Director
70,000 2014-07-31 0

DARRAGH KEITH J. C. VICE PRESIDENT, FINANCE

  • Officer
9,400 2014-06-09 0

KOOB LOTHAR

  • Director
45,000 2013-08-26 0

BIELKE WARREN L

  • Director
45,788 2013-08-26 0

POLSKY BRUCE

  • Director
45,000 2013-08-26 0

ANSARI CYNTHIA F. PRESIDENT AND CEO

  • Officer
  • Director
0 2012-08-13 0

WOLF KATHERINE EXEC. VP, CORP. DEV. & CFO

  • Officer
35,340 2012-07-10 0

ONEDA KATSUMI

  • Director
  • 10% Owner
0 2010-09-02 0

HADANI RON

  • RESIGNING DIRECTOR AND OFFICER
No longer subject to file 2009-11-09 0

ANSTEY KENNETH W

  • SEE REMARKS
No longer subject to file 2009-07-07 0

HIRSCHMANN GIDEON VICE PRESIDENT OF OPERATIONS

  • Officer
0 2009-06-16 0

WALLACE JOHN J

  • Director
No longer subject to file 2009-05-15 0

BABINI CARLOS

  • FORMER EXE V.P. - GLOBAL SALES
No longer subject to file 2009-01-30 0

HANUKA DAVID

  • FORMER VP, RESEARCH & DEVELOP
No longer subject to file 2009-01-06 0

COHEN YOAV M CONSULTANT ( FORMER CFO )

  • Officer
No longer subject to file 2008-10-14 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments